Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyra and parc genes of staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis

Ophthalmic Research

Volumn 42, Issue 1, 2009, Pages 43-48

  Betanzos Cabrera, Gabriel ^a   Juárez Verdayes, Marco A ^b   González González, Gabriel ^b   Cancino Díaz, Mario E ^b   Cancino Díaz, Juan C ^b,c  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE HIDALGO   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c Col Santo Tomas Delegación Miguel Hidalgo ^*  (Mexico)

Author keywords

Balofloxacin resistance; Gatifloxacin resistance; GyrA; Moxifloxacin resistance; ParC; Staphylococcus epidermidis

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL DNA; BALOFLOXACIN; CIPROFLOXACIN; GATIFLOXACIN; MESSENGER RNA; MOXIFLOXACIN; PAZUFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RUFLOXACIN;

AGAR DILUTION; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BACTERIUM MUTANT; CLINICAL ARTICLE; CONJUNCTIVITIS; CORNEA ULCER; ENDOPHTHALMITIS; EYE INFECTION; GENE EXPRESSION; GENE MUTATION; GYRA GENE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE; WILD TYPE;

ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CONJUNCTIVITIS; CORNEAL ULCER; DNA GYRASE; DNA TOPOISOMERASE IV; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; QUINOLINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 66149119794     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000219684     Document Type: Article

References (41)

1. Chambers HF: The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178-182.
2. Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Patel MV, Gupte SV, Bhagwat SS, De Souza NJ, Khorakiwala HF: In vitro activity of the new quinolone WCK 771 against staphylococci. Antimicrob Agents Chemother 2004;48:3338-3342.
3. Pfaller MA, Herwaldt LA: Laboratory, clinical, and epidemiological aspects of coagu-lase-negative staphylococci. Clin Microbiol Rev 1988;1:281-299.
4. Hooper DC, Wolfson JS: Fluoroquinolone antimicrobial agents. N Engl J Med 1991;324: 384-394.
5. Piercy EA, Bartaro D, Luby JP, Machowiak PA : Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections. Antimicrob Agents Chemother 1989;33:128-130.
6. Daum TE, Schaberg DR, Terpenning MS, Sottile WS, Kauffman CA: Increasing resis-ta nce of Staphylococcus aureus to ciprof loxacin. Antimicrob Agents Chemother 1990;34: 1862-1863.
7. Isaacs RD, Kunkle PJ, Cohen RL, Smith JW: Ciprofloxacin resistance in epidemic methi-cillin-resistant Staphylococcus aureus . Lancet 1988;ii:843.
8. Schaefler S: Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J Clin Microbiol 1989;27:335-336.
9. Shalit I, Berger SA, Gorea A, Frimerman H: Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital. Antimicrob Agents Chemother 1989;33:593-594.
10. Biedenbach DJ, Jones RN: Fluoroquinolone-resistant Haemophilus inf luenzae: frequency of occurrence and analysis of confirmed strains in the SENTRY Antimicrobial Surveillance Program (North and Latin America). Diagn Microbiol Infect Dis 2000;36:255-259.
11. Davies TA, Goldschmidt AR, Pfleger S, Loeloff M, Bush K, Sahm DF, Evangelista A: Cross-resistance, relatedness and allele analysis of fluoroquinolone-resistant US clinical isolates of Streptococcus pneumonia (1998-2000). J Antimicrob Chemother 2003;52:168-175.
12. Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF: Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002). Clin Infect Dis 2003;36:963-970.
13. Thornsberry C, Sahm DF, Kelly LJ, Critchley IA, Jones ME, Evangelista AT, Karlowsky JA: Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program 1999-2000. Clin Infect Dis 2002;34(suppl 1):S4-S16.
14. Pestova E, Millichap JJ, Noskin GA, Peterson LR: Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones. J Antimicrob Chemot her 2000;45:583-590.
15. Gellert M, Mizuuchi K, O'Dea MH, Itoh T, Tomizawa JI: Nalidixic acid resistance: a second genetic character involved in DNA gyrAse activity. Proc Natl Acad Sci USA 1977; 74:4772-4776.
16. Gellert M, Mizuuchi K, O'Dea MH, Nash HA: DNA gyrAse: an enzyme that introduces superhelical turns into DNA. Proc Natl Acad Sci USA 1976;73:3872-3876.
17. Juárez-Verdayes MA, Reyes-López MA, Cancino-Díaz ME, Muñoz-Salas S, Rodrí-guez-Martínez S, Zavala-Díaz de la Serna FJ, Hernández-Rodríguez CH, Cancino-Díaz JC: Isolation, vancomycin resistance and biofilm production of Staphylococcus epidermidis from patients with conjunctivitis, cor-neal ulcers, and endophthalmitis. Rev Latinoam Microbiol 2006;48:238-246.
18. Jhanji V, Sharma N, Satpathy G, Titiyal J: Fourth-generation fluoroquinolone-resis-tant bacterial keratitis. J Cataract Refract Surg 2007; 33:1488-1489.
19. Donnenfeld ED, O'Brien TP, Solomon R, Perry HD, Speaker MG, Wittpenn J: Infectious keratitis after photorefractive keratectomy. Ophtha lmology 2003;110:743-747.
20. Sechi LA, Pinna A, Pusceddu C, Fadda G, Carta F, Zanetti S: Molecular characterization and antibiotic susceptibilities of ocular isolates of Staphylococcus epidermidis . J Clin Microbiol 1999;37:3031-3033.
21. Pinna A, Zanetti S, Sotgiu M, Sechi LA, Fadda G, Carta F: Identification and antibiotic susceptibility of coagulase negative staphylococci isolated in corneal/external infections. Br J Opht ha lmol 1999;83:771-773.
22. Snyder ME, Katz HR: Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1992;114:336-338.
23. Rodríguez-Martínez S, Cancino-Díaz ME, Jiménez-Zamudio L, García-Latorre E, Cancino-Díaz JC: TLRs and NOD mRNA expression pattern in healthy mouse eye. Br J Ophthalmol 2005;89:904-910.
24. Fisch A, Salvanet A, Prazuck T, Forestier F, Gerbaud L, Coscas G, Lafaix C: Epidemiology of infective endophthalmitis in France. The French Collaborative Study Group on Endophthalmitis. Lancet 1991;338:1373-1376.
25. Upadhyay MP, Karmacharya PC, Koirala S, Tuladhar NR, Bryan LE, Smolin G, Whitcher JP: Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol 1991;111:92-99.
26. Benz MS, Scott IU, Flynn HW Jr, Unonius N, Miller D: Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol 2004;37:38-42.
27. Schwalbe R, Stapleton JT, Gilligan PH: Emergence of vancomycin resistance in coagu-lase-negative staphylococci. N Engl J Med 1987;316:927.
28. Ohnsman C, Ritterband D, O' Brien T, Girgis D, Kabat A: Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis. Curr Med Res Opin 2007;23:2241-2249.
29. Yamada M, Yoshida J, Hatou S, Yoshida T, Minagawa Y: Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Br J Ophthalmol 2008;92:848-851.
30. Bogado I, Limansky A, Sutich E, Marchiaro P, Marzi M, Putero J, Viale A: Molecular characterization of methicillin-resistant coagulase-negative staphylococci from a neonatal intensive care unit. Infect Control Hosp Epidemiol 2002;23:447-451.
31. de Mattos EM, Teixeira LA, Alves VM, Rezenda e Resende CA, da Silva Coimbra MV, da Silva-Carvalho MC, Ferreira-Car-valho BT, Figueiredo AM: Isolation of methicillin-resistant coagulase-negative staphylococci from patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and comparison of different molecular techniques for discriminating isolates of Staphylococcus epidermidis . Diagn Microbiol Infect Dis 2003;45:13-22.
32. Galdbart JO, Morvan A, Desplaces N, ElSolh N: Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses. J Clin Microbiol 1999;37:1306-1312.
33. Miragaia M, Couto I, Pereira SFF, Kristins-son KG, Westh H, Jarlov JO, Carrico J, Almeida J, Santo-Sanches I, de Lencastre H: Molecular characterization of methicillinresistant Staphylococcus epidermidis clones: evidence of geographic dissemination. J Clin Microbiol 2002;40:430-438.
34. Nunes AP, Teixeira LM, Bastos CC, Silva MG, Ferreira RB, Fonseca LS, Santos KR: Genomic characterization of oxacillin-resistant Staphylococcus epidermidis and Staphylococcus haemolyticus isolated from Brazilian medical centres. J Hosp Infect 2005;59:19-26.
35. Dominguez MA, Linares L, Pulido A, Perez JL, de Lencastre H: Molecular tracking of coagulase-negative staphylococcal isolates from catheter-related infections. Microb Drug Resist 1996;2:423-429.
36. Sreedharan S, Peterson LR, Fisher LM: Ciprofloxacin resistance in coagulase-positive and -negative staphylococci: role of mutations at serine 84 in the DNA gyrAse A protein of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 1991;35:2151-2154.
37. Li Z, Deguchi T, Yasuda M, Kawamura T, Kanematsu E, Nishino Y, Ishihara S, Kawada Y: Alteration in the GyrA subunit of DNA gyrAse and the ParC subunit of DNA topoisomerase IV in quinolone-resistant clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother 1998;42:3293-3295.
38. Linde HJ, Schmidt M, Fuchs E, Reischl U, Niller HH, Lehn N: In vitro activities of six quinolones and mechanisms of resistance in Staphylococcus aureus and coagulase-negative staphylococci. Antimicrob Agents Chemother 2001;45:1553-1557.
39. Masahiro T, Yonezawa M, Matsubara N, Watanabe Y, Narita H, Matsunaga T, Igarashi H, Kawahara M, Onodera S, Oishi Y: Antibacterial activity of quinolones against coagulase-negative staphylococci and the quinolone resistance- determining region of the gyrA genes from six species. J Antimicrob Chemother 1997;40:383-386.
40. Avsaroglu MD, Helmuth R, Junker E, Hertwig S, Schroeter A, Akcelik M, Bozoglu F, Guerra B: Plasmid-mediated quinolone resistance conferred by qnrS1 in Salmonella enterica serovar Virchow isolated from Turkish food of avian origin. J Antimicrob Chemother 2007;60:1146-1150.
41. Ince D, Hooper DC: Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus. Antimicrob Agents Chemother 2001;45:2755-2764.